Avalo Therapeutics (AVTX) Prepaid Assets (2014 - 2026)

Avalo Therapeutics (AVTX) has 13 years of Prepaid Assets data on file, last reported at $6.7 million in Q1 2026.

• Quarterly Prepaid Assets rose 264.7% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 264.7% YoY) and the FY2025 annual result came in at $6.9 million, up 59.84% from the prior year.
• Prepaid Assets slipped to $6.7 million in Q1 2026, from $6.9 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $6.9 million in Q4 2025 to a low of $100000.0 in Q1 2024.
• A 5-year average of $2.1 million and a median of $1.6 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2024 — Prepaid Assets plunged 93.85% — and 2025, when it soared 1803.0%.
• Tracing AVTX's Prepaid Assets over 5 years: stood at $1.3 million in 2022, then slumped by 61.24% to $500000.0 in 2023, then soared by 765.0% to $4.3 million in 2024, then jumped by 59.84% to $6.9 million in 2025, then decreased by 3.3% to $6.7 million in 2026.
• The last three Prepaid Assets figures came in at $6.7 million (Q1 2026), $6.9 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.